These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24162028)

  • 1. [Do we have a good blood supply?].
    Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Oct; 56(10):1349-51. PubMed ID: 24162028
    [No Abstract]   [Full Text] [Related]  

  • 2. [Minimum requirements for the microbiological control of blood components for transfusion. Update of the vote 16].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Mar; 56(3):474-5. PubMed ID: 23455562
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Medical Products Agency should supervise blood production. Disagreement concerning men who had sexual contacts with men has brought matters to a head].
    Söderström T
    Lakartidningen; 2011 Sep 28-Oct 4; 108(39):1894. PubMed ID: 22111225
    [No Abstract]   [Full Text] [Related]  

  • 4. [Testing of medicinal products produced from pooled plasma].
    Unkelbach U; Hunfeld A; Breitner-Ruddock S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1181-4. PubMed ID: 25213735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cells, plasma, and other new apheresis-derived blood products: improving product quality and donor utilization.
    Smith JW; Gilcher RO
    Transfus Med Rev; 1999 Apr; 13(2):118-23. PubMed ID: 10218235
    [No Abstract]   [Full Text] [Related]  

  • 6. Counterfeit medicines kill.
    Manchester A
    Nurs N Z; 2005 Apr; 11(3):10. PubMed ID: 16529205
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy with cellular blood components].
    Eichler H; Klüter H
    Internist (Berl); 2001 May; 42(5):760-8. PubMed ID: 11400584
    [No Abstract]   [Full Text] [Related]  

  • 8. The quality of blood products in Mississippi takes another leap forward.
    Jett PL
    J Miss State Med Assoc; 1999 Nov; 40(11):390-1. PubMed ID: 10568090
    [No Abstract]   [Full Text] [Related]  

  • 9. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 May; 80(99):29841-906. PubMed ID: 26003966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Report on notifications pursuant to Section 21 of the German Transfusion Act for the years 2008 and 2009].
    Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Oct; 53(10):1089-103. PubMed ID: 20936454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The German approach to apheresis guidelines.
    Kretschmer V
    Transfus Sci; 1990; 11(3-4):309-11. PubMed ID: 10149531
    [No Abstract]   [Full Text] [Related]  

  • 12. [Checking of blood product in hospital].
    Girard A
    Transfus Clin Biol; 2004 Oct; 11(4):205-9. PubMed ID: 15564102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice.
    Vamvakas EC
    Transfusion; 2013 Apr; 53(4):888-901. PubMed ID: 22882177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not Available].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Oct; 58(10):1126-8. PubMed ID: 26411732
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood products].
    Montloin A
    Rev Infirm; 1992 Mar; 42(6):33-41. PubMed ID: 1598492
    [No Abstract]   [Full Text] [Related]  

  • 16. ['Variant of Creutzfeldt-Jacob disease and blood transfusion'; report of the Dutch Health Council].
    van Aken WG
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1444-7. PubMed ID: 11503311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Oct; 58(10):1129-50. PubMed ID: 26411733
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukocyte reduction of blood components: public policy and new technology.
    Dzik S; Aubuchon J; Jeffries L; Kleinman S; Manno C; Murphy MF; Popovsky MA; Sayers M; Silberstein LE; Slichter SJ; Vamvakas EC
    Transfus Med Rev; 2000 Jan; 14(1):34-52. PubMed ID: 10669939
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood components: indication and notice of transfusion].
    Sekiguchi S
    Nihon Rinsho; 1997 Sep; 55(9):2205-13. PubMed ID: 9301278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quality assurance management system for therapy with blood and blood products].
    Diekamp U
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):664-5. PubMed ID: 9825053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.